e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Tuberculosis in immunocompromised hosts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary drug resistance in HIV/TB patients
V. Zimina, I. Vasilyeva, A. Kravtchenko, F. Batirov, I. Viktorova (Moscow, Novokuznetsk, Russian Federation)
Source:
Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Session:
Tuberculosis in immunocompromised hosts
Session type:
Poster Discussion
Number:
1937
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Zimina, I. Vasilyeva, A. Kravtchenko, F. Batirov, I. Viktorova (Moscow, Novokuznetsk, Russian Federation). Primary drug resistance in HIV/TB patients. Eur Respir J 2011; 38: Suppl. 55, 1937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Primary and acquired drug resistance in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005
Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Bedaquiline in treatment of TB/HIV co-infection patients with extremely-drug resistance of MBT
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
MDR-TB and XDR-TB: drug resistance and treatment outcomes
Source: Eur Respir J 2009; 34: 778
Year: 2009
Primary drug resistance in HIV/tuberculosis patients in two large cities of Siberia
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Primary drug resistance rates in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003
Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
Effectiveness of the intensive phase of chemotherapy in pulmonary TB patients with primary drug resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
Predictors of death in patients with MDR-TB and HIV
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Prevalance of initial and acquired resistance to antituberculosis drugs in our clinic
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005
Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Antituberculosis drug resistance rates in patients newly diagnosed with TB in Istanbul
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Immunologic recovery in HIV/TB co-infected patients after anti-TB treatment
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
The relapses of tuberculosis with multiple drug resistance among patients treated under DOTS-Plus regimen
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept